Dr Mary Lou Chatterton
Senior Research Fellow & Co-Program Lead, Mental Health
Doctorate in Clinical Pharmacy
State: VIC
Clincial areas of expertise:Mental Health, Substance use, Psychology, Neurology
Cost effectiveness modelling, Health economic evaluation alongside cluster trials, Trial-based economic evaluation, Analysing linked administrative data
Extensive experience with design, implementation and reporting of trial based economic evaluations including cluster randomised trials Experience developing economic models for economic evaluation and budget impact Experience analysing linked administrative data
Chatterton ML, Harris M, Burgess P, Fletcher S, Spittal MJ, Faller J, Palmer VJ, Chondros P, Bassilios B, Pirkis J, Gunn J,
Mihalopoulos C. Economic evaluation of a Decision Support Tool to guide intensity of mental health care in general practice: the Linkme pragmatic randomised controlled trial. BMC Primary Care 23:236 (2022). https://doi.org/10.1186/s12875-022-01839-z
Chatterton ML, Rapee RM, Catchpool M, Lyneham HJ,Wuthrich V, Hudson JL, Kangas M, Mihalopoulos C. Economic evaluation of a
stepped care approach for the management of childhood anxiety disorders. Australian & New Zealand Journal of Psychiatry 2019.
doi.org/10.1177%2F0004867418823272 .
Chatterton ML, Mihalopoulos C, O’Neil A, Itsiopoulos C, Opie R, Castle D, Dash S, Brazionis L, Berk M, Jacka F. Economic evaluation
of a dietary intervention for adults with major depression (the “SMILES” trial). BMC Public Health 2018. https://doi.org/10.1186/s12889-
018-5504-8